Immune thrombocytopenia in infants: a retrospective study with comparison to toddlers
1Children's Haematology and Cancer Centre, Mount Elizabeth Hospital, Singapore.
Insights
Immune thrombocytopenia (ITP) in infants is typically self-limiting, with most cases resolving without treatment. Infants with ITP experienced milder bleeding and less chronic illness compared to toddlers.
Area of Science:
- Pediatrics
- Hematology
- Immunology
Background:
- Immune thrombocytopenia (ITP) is a common acquired bleeding disorder in childhood.
- Clinical course and outcomes for infants with ITP remain poorly understood.
Purpose of the Study:
- To compare the clinical course and outcomes of immune thrombocytopenia (ITP) in infants versus toddlers.
- To identify factors influencing ITP in young children.
Main Methods:
- Retrospective study of infants (1-12 months) and toddlers (13-47 months) diagnosed with ITP over 13 years.
- Comparison of demographics, bleeding severity, platelet counts, illness duration, chronic ITP development, treatment, and vaccination history.
Main Results:
- Infants (n=22) generally had milder bleeding (86.4%) and required less treatment (31.8%) than toddlers (n=30).
- Thrombocytopenia resolved in a mean of 1.90 months for infants.
- Fewer infants developed chronic ITP (4.5% vs. 30%, P=0.032), but more had recent vaccination history (59.1% vs. 3.3%, P<0.001).
Conclusions:
- Immune thrombocytopenia in infants is predominantly a self-limiting and transient condition.
- Most infant ITP cases do not necessitate medical intervention.
- Infants with ITP show favorable outcomes with lower rates of chronic disease compared to toddlers.
Introduction:
Immune thrombocytopenia (ITP) is the most common cause of acquired bleeding in childhood, but little is known about the clinical course and outcomes in infants with ITP.
Methods:
This is a retrospective study of all infants (1-12 months of age) and toddlers (13-47 months of age) diagnosed with ITP from a single centre during a 13-year period. The following data were compared between the two patients groups: demographics, severity of bleeding, platelet counts, duration of illness, development of chronic ITP, treatment and association with recent vaccination.
Results:
Twenty-two infants and 30 toddlers were diagnosed and followed up for ITP during the study period. Infants with ITP generally had minor or mild bleeding (19, 86.4%) and seldom required treatment (7, 31.8%), and their thrombocytopenia resolved at a mean of 1.90 months after diagnosis. Besides age, the sex ratio, severity of bleeding, platelet counts and proportion that required treatment were comparable between infants and toddlers. Fewer infants developed chronic ITP (1/22 vs. 9/30, P = 0.032), but more infants had a history of vaccination in the preceding 6 weeks prior to diagnosis of ITP (13/22 vs. 1/30, P < 0.001).
Conclusion:
ITP in infants is almost always a self-limiting and transient illness, and the majority of cases do not require treatment.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:15Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...